Dr. Bayraktar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3825 Teays Valley Rd
Ste 5
Hurricane, WV 25526Phone+1 304-388-4949Fax+1 304-757-7566
Education & Training
- MD Anderson Cancer CenterFellowship, Bone Marrow Transplantation, 2010 - 2011
- University of Miami School of BusinessMBA, Business Administration in Health Sector Management and Policy, 2009 - 2010
- University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2010
- One Brooklyn Health System/Interfaith Medical CenterResidency, Internal Medicine, 2004 - 2007
- Hacettepe University FOMClass of 2003
- Oklahoma UniversityUndergraduate, 1995 - 1996
Certifications & Licensure
- OH State Medical License 2024 - 2026
- MA State Medical License 2024 - 2024
- WV State Medical License 2018 - 2024
- CO State Medical License 2019 - 2021
- KS State Medical License 2018 - 2021
- TX State Medical License 2010 - 2021
- WI State Medical License 2019 - 2021
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Best Clinical Studies Poster Award Sylvester Comprehensive Cancer Center, 2010
- Tuition Award for MBA University of Miami, 2008
Publications & Presentations
PubMed
- 191 citationsImproved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell TransplantationStefan O. Ciurea, Victor E. Mulanovich, Rima M. Saliba, Ulas D. Bayraktar, Ying Jiang
Biology of Blood and Marrow Transplantation. 2012-12-01 - 76 citationsTreatment of FLT3-ITD-Positive Acute Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation with SorafenibManish Sharma, Farhad Ravandi, Ulas D. Bayraktar, Alexandre Chiattone, Qaiser Bashir
Biology of Blood and Marrow Transplantation. 2011-12-01 - 77 citationsThe clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus.Ulas D. Bayraktar, Doruk Erkan, Silvia Bucciarelli, Gerard Espinosa, Ronald A. Asherson
The Journal of Rheumatology. 2007-02-01
Journal Articles
- The role of tyrosine kinase inhibitors in the treatment of advanced hepatocellular carcinoma.Bayraktar UD, Journal of Hepato-Gastroenterology
Books/Book Chapters
Abstracts/Posters
- High-Dose Methotrexate and Azidothymidine in Combination with Alternating DA-EPOCH Is An Effective Regimen for the Treatment of EBV-Related Plasmablastic Lymphoma.Bayraktar UD, Ochoa R, Bayraktar S, Matsangou M, Ramos JC, Blood (ASH Annual Meeting Abstracts)
- Desmoid tumor disguised as a pleural lesion.Theophyllus E, Bayraktar UD, Schmidt S, et al, Chest
- Catastrophic antiphospholipid syndrome (CAPS): Comparison between primary CAPS and lupus-associated CAPS.Bayraktar UD, Erkan D, Asherson R, et al, Arth Rheumat
- Join now to see all
Lectures
- Hematopoietic Cell Transplantation - Specific Comorbidity Index As An Instrument to Predict Survival in Patients Admitted to Intensive Care Unit Early After Allogeneic...53rd ASH Annual Meeting and Exposition, San Diego, CA
- Tyrosine kinase inhibitors in the treatment of hepatocellular carcinoma.International Association of Surgeons, Gastroenterologists, and Oncologists, Istanbul, Turkey
- Relevance and factors predicting for early lymphocyte recovery after allogeneic bone marrow stem cell transplantation.54th ASH Annual Meeting and Exposition, Atlanta, GA
- Join now to see all
Other
- Successful treatment of anal gland adenocarcinoma with combined modality therapy.Warsch S, Bayraktar UD, Wen B, Zeitouni J, Marchetti F, Rocha-Lima CM, Montero AJ
- Outcome of patients with relapsed/refractory AIDS-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS malignancy consortium.Bayraktar UD, Ramos JC, Petrich A, et al
- Vitamin D receptor upregulation in alloreactive human T cells.Joseph RW, Bayraktar UD, Kim TK, et al
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish, Turkish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: